Quick service diagnostics platform Fastest.Health raises Rs 1.2 crore led by Inflection Point Ventures

Quick Service Diagnostics platform (QSD) Fastest.Health has raised Rs 1.2 crore in a pre-seed funding round led by Inflection Point Ventures, a Gurugram-based angel investment platform.

Advertisment

The startup will use the funding to scale marketing initiatives, improve sales, invest in technological advancement and onboard key resources to streamline operations.

Currently, it is operational in the regions of Navi Mumbai and Mumbai's suburban areas and plans to expand in new markets to meet India's growing demand for quick, reliable, and convenient diagnostic solutions.

Co-founded by a team of industry veterans who specialise in diagnostics, logistics, ecommerce and technology. The leadership team includes Jayesh Kamat, CEO, Sandeep Krishna, CBO, Mazhar Faruqi, COO, Dr. Santosh Wakchaure, CMO and Mohit Lala, CTO.

The Mumbai-based healthtech startup offers on-demand diagnostics testing, with sample collection at doorstep within 15 minutes and report delivery to the patients mobile app for most routine tests within 90 minutes. These samples are tested in registered NABL accredited labs thereby offering accurate reports, the release notes.

“With our 15-minute doorstep collection and 90-minute report delivery, we’re not just delivering reports faster, we’re building India’s first true quick-commerce diagnostics network. Our goal is to make Fastest.Health the first and fastest responder for any medical need, ensuring care reaches people exactly when it matters most,” said Sandeep Krishna, Co-founder and CBO Fastest.Health.

Vinay Bansal, Founder IPV, said, “The healthcare sector has undergone a paradigm shift post the covid crisis. Now, the emphasis is not only on accuracy but also on speed, convenience and reliability. Tech plays a major role in making healthcare accessible. Fastest.Health exemplifies this evolution by delivering faster diagnostic results without compromising credibility thereby eliminating delay in starting the treatment which is one of the most important factors in healthcare especially during crucial moments.”

According to the company's statement, the Indian diagnostics market in 2023 was approximately worth $14 billion and is projected to increase to nearly $20 billion in 2026.